Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026 Oliver Barnes / Financial Times : Financial Times 2025-10-30 Clario, Life sciences, Oliver Barnes / Financial Times, Thermo Fisher